| Susan Ranae Battle, FNP | |
|
5 Centerpointe Dr, Lake Oswego, OR 97035-8651 | |
| (541) 214-6301 | |
| (855) 510-1784 |
| Full Name | Susan Ranae Battle |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Family |
| Location | 5 Centerpointe Dr, Lake Oswego, Oregon |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003064304 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | 18370 (California) | Secondary |
| 363LF0000X | Nurse Practitioner - Family | 201050104NP (Oregon) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Susan Ranae Battle, FNP 5 Centerpointe Dr, Lake Oswego, OR 97035-8651 Ph: (541) 214-6301 | Susan Ranae Battle, FNP 5 Centerpointe Dr, Lake Oswego, OR 97035-8651 Ph: (541) 214-6301 |
News Archive
Forty-five years. That's how long it's been since the last drug - rifampin - hit the market to treat tuberculosis, an infection that affects nearly one third of the world's population and causes 1.8 million deaths annually. The University of Illinois at Chicago College of Pharmacy has received three new federally-funded grants to hasten the discovery of new therapeutic treatments.
The first study to look at simplified English-language consent forms translated into another language calls into question the common belief that a translated consent form meets readability standards. The study appears in IRB: Ethics & Human Research.
Elsevier, a world-leading provider of scientific, technical, and medical information products and services, today announced the launch of the International Journal of Surgery Open (IJS Open), a new open access journal covering all areas of surgery.
IMBiotechnologies Ltd., a privately held biotechnology company focused on developing medical device products for use in the area of embolotherapy, today announced that it has received regulatory concurrence from the United States Food and Drug Administration to market its lead product, Occlusin 500 Artificial Embolization Device in the U.S. for the treatment of unresectable/inoperable hypervascularized tumours.
Some babies diagnosed with and treated for a bone marrow failure disorder, called Diamond Blackfan Anemia, may actually be affected by a very rare anemia syndrome that has a different disease course and treatment, say scientists from Dana-Farber/Boston Children's Cancer and Blood Disorders Center.
› Verified 8 days ago
Krisa Fenton, FNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 5 Centerpointe Dr Ste 600, Lake Oswego, OR 97035 Phone: 615-465-9443 | |
Miss Amanda Magdalena Kinder, FNP-C Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 4103 Mercantile Dr, Lake Oswego, OR 97035 Phone: 503-850-9940 | |
Mrs. Amanda L Swinehart, NNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 5299 Lakeview Blvd, Lake Oswego, OR 97035 Phone: 740-215-1612 | |
Dr. Kristine Susan White, DNP, PMHNP-BC Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 14523 Westlake Dr Ste 25, Lake Oswego, OR 97035 Phone: 503-854-7160 Fax: 503-886-8961 | |
Anthony Hernandez, Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 5 Centerpointe Dr Ste 600, Lake Oswego, OR 97035 Phone: 503-603-7355 | |
Tierney Newman, FNP-C Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 4004 Kruse Way Pl Ste 300, Lake Oswego, OR 97035 Phone: 503-216-1500 |